Inovio Pharmaceuticals INO
NASDAQ INO
$1.18 -0.03 (-2.07%)
As of: Oct 2, 2026 · 11:15 AM EDT

Inovio Pharmaceuticals (INO) Total Non-Current Liabilities (2010 - 2022)

Updated

Inovio Pharmaceuticals (INO) recorded Total Non-Current Liabilities of $126.17 million in Q4 2022, up 31.1% from $96.26 million a year earlier and up 1.3% from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Total Non-Current Liabilities (2010 - 2022) Analysis & Trends

Starting with Q4 2010, Inovio Pharmaceuticals' Total Non-Current Liabilities history includes 48 quarters.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 28.8% (FY2017 to FY2022).
  • Across earlier years, Total Non-Current Liabilities came in at $96.26 million in FY2021 (+22.5%), $78.57 million in FY2020 (-39.4%), $129.73 million in FY2019 (+264.8%) and $35.56 million in FY2018 (-0.2%).
  • Quarterly Total Non-Current Liabilities has ranged from $28.31 million in Q3 2018 to $161.73 million in Q2 2022 over the past five years.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for five consecutive quarters, with growth averaging 14.1% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 291.7% in Q3 2019, against a decline of 43.3% in Q1 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $124.56 million (Q3 2022), $161.73 million (Q2 2022) and $90.43 million (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Inovio Pharmaceuticals 99.58 Mn 99.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 126.17 Mn
Sep 30, 2022 124.56 Mn
Jun 30, 2022 161.73 Mn
Mar 31, 2022 90.43 Mn
Dec 31, 2021 96.26 Mn
Sep 30, 2021 82.13 Mn
Jun 30, 2021 83.22 Mn
Mar 31, 2021 73.19 Mn
Dec 31, 2020 78.57 Mn
Sep 30, 2020 113.77 Mn
Jun 30, 2020 137.03 Mn
Mar 31, 2020 129.03 Mn
Dec 31, 2019 129.73 Mn
Sep 30, 2019 110.91 Mn
Jun 30, 2019 108.54 Mn
Mar 31, 2019 110.14 Mn
Dec 31, 2018 35.56 Mn
Sep 30, 2018 28.31 Mn
Jun 30, 2018 28.61 Mn
Mar 31, 2018 51.60 Mn
API Access

Inovio Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INO&period=max&api_key=YOUR_API_KEY